Influence of obesity on control in asthmatic Japanese patients defined by the Japanese definition of obesity

Internal Medicine

Volumn 50, Issue 18, 2011, Pages 1911-1916

  Youkou, Akira ^a   Hasegawa, Takashi ^b   Suzuki, Kazuo ^a   Koya, Toshiyuki ^a   Sakagami, Takuro ^a   Toyabe, Shinichi ^b   Arakawa, Masaaki ^a   Gejyo, Fumitake ^a   Narita, Ichiei ^a   Suzuki, Eiichi ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Bronchial asthma; Disease severity; Inhaled corticosteroid; Obesity

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; SALMETEROL; THEOPHYLLINE; TULOBUTEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BODY MASS; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; QUESTIONNAIRE; SCORING SYSTEM; SUSTAINED DRUG RELEASE;

ADRENAL CORTEX HORMONES; ADULT; AGED; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; HUMANS; INCIDENCE; JAPAN; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; OBESITY; PATIENT SATISFACTION; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80052833047     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5474     Document Type: Article

References (36)

1. Hasegawa T, Suzuki E, Terada M, et al. Improvement of asthma management in actual practice consistent with prevalence of antiinflammatory agents: based on Questionnaire Surveys in Niigata Prefecture, Japan from 1998 to 2002. Allergol Int 54: 555-563, 2005.
2. Hasegawa T, Suzuki E, Muramatsu Y, et al. Questionnaire-based analysis of the current level of asthma control and management in Niigata Prefecture, Japan: changes from 1998 to 2000. Allergol Int 53: 135-144, 2004.
3. Masoli M, Fabian D, Holt S, Beasley R. Global initiative for asthma (GINA) program. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 59: 469-478, 2004.
4. Lai CK, De Guia TS, Kim YY, et al. Asthma insights and reality in Asia-Pacific steering committee. asthma control in the Asia-Pacific region: the asthma insights and reality in Asia-Pacific study. J Allergy Clin Immunol 111: 263-268, 2003.
5. Weiss KB, Sullivan SD. The economic costs of asthma: a review and conceptual model. Pharmacoeconomics 41: 14-30, 1993.
6. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 174: 112-119, 2006.
7. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 175: 661-666, 2007.
8. Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 92: 32-39, 2004.
9. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 178: 682-687, 2008.
10. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 101: 2240-2247, 2007.
11. Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 27: 495-503, 2006.
12. Weiss ST, Shore S. Obesity and asthma: directions for research. Am J Respir Crit Care Med 169: 963-968, 2004.
13. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 26: 968-976, 2006.
14. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 52: 1749-1757, 2008.
15. Hill MJ, Metcalfe D, McTernan PG. Obesity and diabetes: lipids,'nowhere to run to'. Clin Sci (Lond) 116: 113-123, 2009.
16. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5: 136-143, 2008.
17. Fernâdez JR, Allison DB. Understanding racial differences in obesity and metabolic syndrome traits. Nutr Rev 61: 316-319, 2003.
18. Lee S, Kuk JL, Hannon TS, Arslanian SA. Race and gender differences in the relationships between anthropometrics and abdominal fat in youth. Obesity (Silver Spring) 16: 1066-1071, 2008.
19. Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes (Lond) 35: 167-187, 2011.
20. Li G, Chen X, Jang Y, et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes Rev 3: 167-172, 2002.
21. Moon OR, Kim NS, Jang SM, Yoon TH, Kim SO. The relationship between body mass index and the prevalence of obesityrelated diseases based on the 1995 National Health Interview Survey in Korea. Obes Rev 3: 191-199, 2002.
22. Deurenberg-Yap M, Chew SK, Lin VF, et al. Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord 25: 1554-1562, 2001.
23. Suzuki E, Hasegawa T, Koya T, et al. Questionnaire-based analysis of current status of adult bronchial asthma in Niigata Prefecture: comparison with the Asthma Guideline. Acta Medica Biologica 50: 135-143, 2002.
24. Suzuki E, Hasegawa T, Koya T, et al. Questionnaire-based characterization of bronchial asthma in elderly: analysis in Niigata Prefecture, Japan. Allergol Int 51: 241-248, 2002.
25. Yoshimine F, Hasegawa T, Suzuki E, et al. Contribution of aspirin intolerant asthma to near fatal asthma based on questionnaire surveys in Niigata Prefecture, Japan. Respirology 10: 477-484, 2005.
26. Suzuki K, Hasegawa T, Sakagami T, et al. Analysis of perimenstrual asthma based on questionnaire surveys in Japan. Allergol Int 56: 249-255, 2007.
27. Koyanagi K, Koya T, Sasagawa M, et al. An analysis of factors that exacerbate asthma, based on a Japanese questionnaire. Allergol Int 58: 519-527, 2009.
28. Ota K, Hasegawa T, Koya T, et al. Analysis of inhaled corticosteroid selection in patients with bronchial asthma using a questionnaire survey: Effects of age, gender, and disease severity. Allergol Int 58: 365-371, 2009.
29. Satoh H, Hasegawa T, Suzuki E, et al. Gender differences in susceptibility of asthma to active smoking: questionnaire based analysis in the Niigata Prefecture, Japan. Allergol Int 54: 401-410, 2005.
30. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113: 59-65, 2004.
31. Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 117: 549-556, 2006.
32. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919, 2005.
33. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788, 2003.
34. Fredberg JJ, Inouye DS, Mijailovich SM, Butler JP. Perturbed equilibrium of myosin binding in airway smooth muscle and its implications in bronchospasm. Am J Respir Crit Care Med 159: 959-967, 1999.
35. Giouleka P, Papatheodorou G, Lyberopoulos P, et al. Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Invest 41: 30-38, 2011.
36. Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 27: 495-503, 2006.